Medicares $50 obesity drug program sees huge demand

Medicare's $50 monthly obesity drug program, launched in July, has filled over 200,000 prescriptions at CVS and Walgreens. The Bridge program targets eligible beneficiaries, though those with sleep apnea or diabetes are excluded. Demand exceeded expectations, with millions potentially qualifying.